These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27209524)

  • 21. Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort.
    Andrianarisoa M; Boyer L; Godin O; Brunel L; Bulzacka E; Aouizerate B; Berna F; Capdevielle D; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Llorca PM; Mallet J; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Tronche AM; Urbach M; Vidailhet P; Schürhoff F; Fond G;
    Schizophr Res; 2017 Jul; 185():173-181. PubMed ID: 28109668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early trauma, attachment experiences and comorbidities in schizophrenia.
    Gabínio T; Ricci T; Kahn JP; Malaspina D; Moreira H; Veras AB
    Trends Psychiatry Psychother; 2018; 40(3):179-184. PubMed ID: 29641648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
    Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
    Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder.
    Ringen PA; Melle I; Berg AO; Agartz I; Spigset O; Simonsen C; Sundet K; Andreassen OA
    Schizophr Res; 2013 Jan; 143(1):84-9. PubMed ID: 23178107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.
    van der Meer FJ; Velthorst E;
    Psychol Med; 2015 Jul; 45(9):1977-88. PubMed ID: 25654244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between insight and self-reported quality of life among shizophrenic patients].
    Aghababian V; Auquier P; Baumstarck-Barrau K; Lançon C
    Encephale; 2011 Jun; 37(3):162-71. PubMed ID: 21703431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The history of childhood trauma among individuals with ultra high risk for psychosis is as common as among patients with first-episode schizophrenia.
    Sahin S; Yüksel Ç; Güler J; Karadayı G; Akturan E; Göde E; Özhan AA; Üçok A
    Early Interv Psychiatry; 2013 Nov; 7(4):414-20. PubMed ID: 23343404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabis use is associated with 3years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N=1119).
    Helle S; Ringen PA; Melle I; Larsen TK; Gjestad R; Johnsen E; Lagerberg TV; Andreassen OA; Kroken RA; Joa I; Ten Velden Hegelstad W; Løberg EM
    Schizophr Res; 2016 Jan; 170(1):217-21. PubMed ID: 26682958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis and brain morphology in recent-onset schizophrenia.
    Cahn W; Hulshoff Pol HE; Caspers E; van Haren NE; Schnack HG; Kahn RS
    Schizophr Res; 2004 Apr; 67(2-3):305-7. PubMed ID: 14984893
    [No Abstract]   [Full Text] [Related]  

  • 31. Variable individual sensitivity to cannabis in patients with schizophrenia.
    Goldberger C; Dervaux A; Gourion D; Bourdel MC; Lôo H; Laqueille X; Krebs MO
    Int J Neuropsychopharmacol; 2010 Oct; 13(9):1145-54. PubMed ID: 20529414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabis use and age at onset of schizophrenia.
    Veen ND; Selten JP; van der Tweel I; Feller WG; Hoek HW; Kahn RS
    Am J Psychiatry; 2004 Mar; 161(3):501-6. PubMed ID: 14992976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging study.
    Bourque J; Mendrek A; Durand M; Lakis N; Lipp O; Stip E; Lalonde P; Grignon S; Potvin S
    Psychiatry Res; 2013 Oct; 214(1):24-32. PubMed ID: 23906663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is cannabis a vulnerability factor in schizophrenic disorders].
    Laqueille X
    Arch Pediatr; 2009 Sep; 16(9):1302-5. PubMed ID: 19640690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study.
    Degenhardt L; Tennant C; Gilmour S; Schofield D; Nash L; Hall W; McKay D
    Psychol Med; 2007 Jul; 37(7):927-34. PubMed ID: 17288638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of cannabis use expectancies on cannabis use and psychotic symptoms in psychosis.
    Hides L; Kavanagh DJ; Dawe S; Young RM
    Drug Alcohol Rev; 2009 May; 28(3):250-6. PubMed ID: 18608451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No interaction between polygenic scores and childhood trauma in predicting suicide attempt in schizophrenia.
    Bani-Fatemi A; Tasmim S; Wang KZ; Warsh J; Sibille E; De Luca V
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():169-173. PubMed ID: 30149093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The meaning of childhood attention-deficit hyperactivity symptoms in patients with a first-episode of schizophrenia-spectrum psychosis.
    Peralta V; de Jalón EG; Campos MS; Zandio M; Sanchez-Torres A; Cuesta MJ
    Schizophr Res; 2011 Mar; 126(1-3):28-35. PubMed ID: 20926260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive functioning and insight in schizophrenia and in schizoaffective disorder.
    Birindelli N; Montemagni C; Crivelli B; Bava I; Mancini I; Rocca P
    Riv Psichiatr; 2014; 49(2):77-83. PubMed ID: 24770573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Craving in patients with schizophrenia and cannabis use disorders.
    Schnell T; Becker T; Thiel MC; Gouzoulis-Mayfrank E
    Can J Psychiatry; 2013 Nov; 58(11):646-9. PubMed ID: 24246436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.